211 related articles for article (PubMed ID: 25230878)
1. Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor.
Füllhase C; Hennenberg M; Sandner P; Strittmatter F; Niedworok C; Bauer RM; Gratzke C; Soler R; Stief C; Andersson KE
Neurourol Urodyn; 2015 Nov; 34(8):787-93. PubMed ID: 25230878
[TBL] [Abstract][Full Text] [Related]
2. The soluble guanylyl cyclase activator BAY 60-2770 ameliorates overactive bladder in obese mice.
Leiria LO; Silva FH; Davel AP; Alexandre EC; Calixto MC; De Nucci G; Mónica FZ; Antunes E
J Urol; 2014 Feb; 191(2):539-47. PubMed ID: 24050894
[TBL] [Abstract][Full Text] [Related]
3. Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity.
Füllhase C; Hennenberg M; Giese A; Schmidt M; Strittmatter F; Soler R; Gratzke C; Andersson KE; Stief C
J Urol; 2013 Oct; 190(4):1430-5. PubMed ID: 23545097
[TBL] [Abstract][Full Text] [Related]
4. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
[TBL] [Abstract][Full Text] [Related]
5. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
[TBL] [Abstract][Full Text] [Related]
6. Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failure.
Oudot A; Behr-Roussel D; Poirier S; Sandner P; Bernabé J; Alexandre L; Giuliano F
Eur Urol; 2011 Nov; 60(5):1020-6. PubMed ID: 21839578
[TBL] [Abstract][Full Text] [Related]
7. Preserved activity of soluble guanylate cyclase (sGC) in iliac artery from middle-aged rats: Role of sGC modulators.
Justo AFO; de Oliveira MG; Calmasini FB; Alexandre EC; Bertollotto GM; Jacintho FF; Antunes E; Mónica FZ
Nitric Oxide; 2021 Jan; 106():9-16. PubMed ID: 33122152
[TBL] [Abstract][Full Text] [Related]
8. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
Bice JS; Keim Y; Stasch JP; Baxter GF
Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501
[TBL] [Abstract][Full Text] [Related]
9. Effects of hydrogen peroxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
Free Radic Res; 2015; 49(12):1479-87. PubMed ID: 26334090
[TBL] [Abstract][Full Text] [Related]
10. Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder.
Werkström V; Hedlund P; Lee T; Andersson KE
BJU Int; 2009 Dec; 104(11):1740-5. PubMed ID: 19694713
[TBL] [Abstract][Full Text] [Related]
11. Soluble guanylate cyclase modulators blunt hyperoxia effects on calcium responses of developing human airway smooth muscle.
Britt RD; Thompson MA; Kuipers I; Stewart A; Vogel ER; Thu J; Martin RJ; Pabelick CM; Prakash YS
Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L537-42. PubMed ID: 26254425
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum.
Estancial CS; Rodrigues RL; De Nucci G; Antunes E; Mónica FZ
BJU Int; 2015 Oct; 116(4):657-64. PubMed ID: 25715977
[TBL] [Abstract][Full Text] [Related]
13. [Effects and mechanisms of phosphodiesterase type 5 inhibitors on rats with overactive bladder].
Chen HD; Ye XT; Weng ZL; Li CD
Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(28):2001-5. PubMed ID: 22093899
[TBL] [Abstract][Full Text] [Related]
14. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
J Cardiovasc Pharmacol; 2015 Feb; 65(2):160-7. PubMed ID: 25329747
[TBL] [Abstract][Full Text] [Related]
15. Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra.
Toque HA; Antunes E; Teixeira CE; De Nucci G
Urology; 2008 Sep; 72(3):711-5. PubMed ID: 18359064
[TBL] [Abstract][Full Text] [Related]
16. Treatment with the soluble guanylate cyclase activator BAY 60-2770 normalizes bladder function in an in vivo rat model of chronic prostatitis.
Aydogdu O; Perez F; Aronsson P; Uyar Gocun P; Carlsson T; Sandner P; Patel B; Winder M
Eur J Pharmacol; 2022 Jul; 927():175052. PubMed ID: 35643304
[TBL] [Abstract][Full Text] [Related]
17. Long-term administration of BAY 41-2272 prevents bladder dysfunction in nitric oxide-deficient rats.
Mónica FZ; Reges R; Cohen D; Silva FH; De Nucci G; D'Ancona CA; Antunes E
Neurourol Urodyn; 2011 Mar; 30(3):456-60. PubMed ID: 21412825
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
Albersen M; Linsen L; Tinel H; Sandner P; Van Renterghem K
J Sex Med; 2013 May; 10(5):1268-77. PubMed ID: 23421435
[TBL] [Abstract][Full Text] [Related]
19. Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma.
Ghosh A; Koziol-White CJ; Asosingh K; Cheng G; Ruple L; Groneberg D; Friebe A; Comhair SA; Stasch JP; Panettieri RA; Aronica MA; Erzurum SC; Stuehr DJ
Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2355-62. PubMed ID: 27071111
[TBL] [Abstract][Full Text] [Related]
20. The effects of cyclic guanylate cyclase stimulation on right ventricular hypertrophy and failure alone and in combination with phosphodiesterase-5 inhibition.
Andersen A; Nielsen JM; Holmboe S; Vildbrad MD; Nielsen-Kudsk JE
J Cardiovasc Pharmacol; 2013 Aug; 62(2):167-73. PubMed ID: 23575263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
